Skip to main content

7 February 2023

Last updated: Monday 6 February 2023

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

The perilous state of antibiotic development

Friday 20 January 2012

Interviewee/Contributor

Helen Boucher

Organisation

Infectious Diseases Society of America (IDSA)

Organisations

Diurnal Group Plc
Mission Therapeutics
Johnson & Johnson Innovation Center, London
IBA Molecular
NEUWAY Pharma GmbH
Intercell AG
BC Platforms AG
Harvard Stem Cell Institute
CEVEC Pharmaceuticals GmbH
Aravis Venture

Interviewees and Contributers

Jean-Philippe Tripet
Erik Manting
Khalid Ishaque
Clare Ozawa
Nicholas McGranahan
Marie Manley and Zina Chatzidimitriadou
Michael Salgaller, Michele Newton and Michael Pollack
Stephan Christgau
Graham Burnett-Hall
Olivier Litzka

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Stephan Witte becomes CMO of Adrenomed

Saturday 4 February 2023

Anton Hoos joins Sobi as CMO

Saturday 4 February 2023

Kristof Van Emelen joins Scenic Biotech

Saturday 28 January 2023

Rachel Abbott is CSO at Pan Cancer T

Saturday 28 January 2023

Jonathan Curtain named CFO at Ergomed

Wednesday 25 January 2023

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2023 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form